"10.1371_journal.pone.0148924","plos one","2016-02-12T00:00:00Z","Luis F López-Cortés; Manuel A Castaño; Miguel A López-Ruz; María J Rios-Villegas; José Hernández-Quero; Dolores Merino; Patricia Jiménez-Aguilar; Manuel Marquez-Solero; Alberto Terrón-Pernía; Francisco Tellez-Pérez; Pompeyo Viciana; Francisco Orihuela-Cañadas; Zaira Palacios-Baena; David Vinuesa-Garcia; Jose M Fajardo-Pico; Alberto Romero-Palacios; Guillermo Ojeda-Burgos; Juan Pasquau-Liaño","Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla, Spain; Hospital Universitario Carlos Haya, Málaga, Spain; Hospital Universitario Virgen de las Nieves, Granada, Spain; Hospital Universitario Virgen Macarena, Sevilla, Spain; Hospital Universitario San Cecilio, Granada, Spain; Complejo Hospitalario Juan Ramón Jiménez, Huelva, Spain; Hospital Universitario de Puerto Real, Cádiz, Spain; Hospital Universitario Virgen de la Victoria, Málaga, Spain; Hospital Jerez de la Frontera, Cádiz, Spain; Hospital La Línea, Cádiz, Spain","Conceived and designed the experiments: LFL. Performed the experiments: LFL MAC MAL MJR JH DM PJ MM AT FT PV FO ZP DV JMF AR GO JP. Analyzed the data: LFL. Contributed reagents/materials/analysis tools: LFL MAC MAL MJR JH DM PJ MM AT FT PV FO ZP DV JMF AR GO JP. Wrote the paper: LFL. Critical revision of the article for important intellectual content: JH DM JP.","FL and PV have received unrestricted grants for research and personal fees for speaking at symposia on behalf of Abbvie laboratories (Spain), Bristol-Myers Squibb, Glaxo Smithkline, Gilead Sciences, Janssen España, Merck Sharp & Dohme España, Roche Pharma SA, and ViiV Healthcare. MAL and MM have received unrestricted research grants and personal fees for speaking at symposia on behalf of Abbott laboratories (Spain), Janssen España, Merck Sharp & Dohme España, and ViiV Healthcare. JP has received unrestricted grants for research and speaker honoraria from Bristol-Myers Squibb, Janssen, Abbvie laboratories, Merck Sharp & Dohme, ViiV Healthcare, Gilead Sciences and Roche Pharma. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials. All other authors have no competing interests to declare.","2016","02","Luis F López-Cortés","LFLC",18,FALSE,1,18,1,1,TRUE,TRUE,FALSE,0,NA,FALSE
